Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Tax Provisions (2018 - 2025)

Historic Tax Provisions for Akebia Therapeutics (AKBA) over the last 3 years, with Q3 2025 value amounting to $615000.0.

  • Akebia Therapeutics' Tax Provisions changed N/A to $615000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $615000.0, marking a year-over-year change of. This contributed to the annual value of -$6.6 million for FY2019, which is 7660.03% up from last year.
  • Latest data reveals that Akebia Therapeutics reported Tax Provisions of $615000.0 as of Q3 2025.
  • In the past 5 years, Akebia Therapeutics' Tax Provisions registered a high of $615000.0 during Q3 2025, and its lowest value of $615000.0 during Q3 2025.